RKLY - Rockley Photonics enter partnership with leading contract research organization

• Rockley Photonics ( NYSE: RKLY ) enters a new partnership with a top ten, global contract research organization (or CRO) that provides full-service clinical development services to biopharmaceutical customers.
• The partners will integrate Rockley’s health monitoring solutions into clinical research studies, including its Bioptx biosensing wristband, cloud services, and other elements of its biomarker sensing platform for continuous, near real-time, non-invasive measurement of multiple biomarkers.
• CRO is expected to use Rockley-powered remote monitoring wearables as a tool for researchers to better understand various factors affecting the health and well-being of trial participants.
• Dr. Andrew Rickman, chairman and CEO said, “Partnering with CROs expands our reach in medtech and creates exciting opportunities for clinicians and researchers to conduct decentralized clinical trials and gain crucial insights into the health and well-being of patients throughout the trial, regardless of their location. With the extended range of biomarker detection and the ability to monitor those biomarkers on a routine basis, Rockley-powered wearables are poised to add a new dimension to clinical research and bring us one step closer to realizing our goal of improving health outcomes for everyone.”

For further details see: